These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Neutralizing antibody titers following revaccination with vaccinia virus. Heering SL; Shohat T; Vonsover A; Mendelson E; Lerman Y Public Health Rev; 1990-1991; 18(1):94-7. PubMed ID: 2132886 [No Abstract] [Full Text] [Related]
4. The titration of vaccinial neutralizing antibody on chorio-allantoic membranes. BOULTER EA J Hyg (Lond); 1957 Dec; 55(4):502-12. PubMed ID: 13491839 [No Abstract] [Full Text] [Related]
5. One-step growth curves for vaccinia virus in cultures of monkey kidney cells. FURNESS G; YOUNGNER JS Virology; 1959 Nov; 9():386-95. PubMed ID: 13825718 [No Abstract] [Full Text] [Related]
6. [Titration on rabbits & on tissue cultures of neutralizing antibodies of serums & milks of cows immunized by vaccinia virus]. FALCHETTI ; MERIEUX J Rev Pathol Gen Physiol Clin; 1958 Mar; 58(696):399-403. PubMed ID: 13555378 [No Abstract] [Full Text] [Related]
7. Three specific antigens produced in vaccinia, variola, and monkeypox infections. Gispen R; Brand-Saathof B J Infect Dis; 1974 Mar; 129(3):289-95. PubMed ID: 4131519 [No Abstract] [Full Text] [Related]
8. [Passive hemagglutination test used as method for detection of antibodies in vaccinia]. Stefănesco V; Mihăilesco R; Grobnico M Arch Roum Pathol Exp Microbiol; 1965 Sep; 24(3):771-8. PubMed ID: 5877882 [No Abstract] [Full Text] [Related]
9. [Antibody picture of variola vaccine infection. I. Varying antibody formation in the vaccine infection of rabbits, monkeys and humans]. HERRLICH A; MAYR A; MUNZ E Zentralbl Bakteriol Orig; 1956 Jun; 166(2):73-83. PubMed ID: 13353533 [No Abstract] [Full Text] [Related]
10. [Study of smallpox and vaccinia antigens and immune serums by the precipitation microreaction in a gelatinized medium]. POURNAKI R; VIEUCHANGE J; LEPINE P Bull Acad Natl Med; 1963 Jan 8-15; 147():11-20. PubMed ID: 13985796 [No Abstract] [Full Text] [Related]
11. THE CYCLE OF MULTIPLICATION OF VACCINIA VIRUS IN EARLE'S STRAIN L CELLS. I. UPTAKE AND PENETRATION. DALES S; KAJIOKA R Virology; 1964 Nov; 24():278-94. PubMed ID: 14227031 [No Abstract] [Full Text] [Related]
12. Antibody to Vaccinia. I. Detection by immunoelectroendosmophoresis. Entwistle CC Vox Sang; 1974; 27(5):459-63. PubMed ID: 4213694 [No Abstract] [Full Text] [Related]
13. THE EFFECT OF HORSE SERUM ON THE QUALITY OF VACCINIA VIRUS GROWN IN L CELL CULTURES. GALASSO GJ; SHARP DG J Immunol; 1963 Apr; 90():647-53. PubMed ID: 14082028 [No Abstract] [Full Text] [Related]
14. VACCINIA VIRUS-HELA CELL INTERACTION. I. THE EFFECT OF IMMUNE SERUM ON THE PRODUCTION OF INFECTIVE VIRUS, COMPLEMENT-FIXING ANTIGEN, AND HEMAGGLUTININ. ODA M Virology; 1963 Aug; 20():552-8. PubMed ID: 14059822 [No Abstract] [Full Text] [Related]
15. Vaccinia virus strain differences. I. Neutralization of vaccinia virus strains by homologous and heterologous antisera. Dunlap RC; Barker LF Arch Gesamte Virusforsch; 1973; 42(2):107-16. PubMed ID: 4126981 [No Abstract] [Full Text] [Related]
16. [TUMOR 62 DISEASE. IV. RESEARCH ON THE ACTION OF SOME IMMUNE SERUMS AGAINST TUMOR 62 ASCITES]. ILIE B Stud Cercet Inframicrobiol; 1964; 15():279-92. PubMed ID: 14214915 [No Abstract] [Full Text] [Related]
17. COMPARATIVE STUDIES OF PIGPOX AND VACCINIA VIRUSES. II. SEROLOGICAL RELATIONSHIP. DATT NS J Comp Pathol; 1964 Jan; 74():70-80. PubMed ID: 14105242 [No Abstract] [Full Text] [Related]
18. Standardization of a neutralizing anti-vaccinia antibodies titration method: an essential step for titration of vaccinia immunoglobulins and smallpox vaccines evaluation. Leparc-Goffart I; Poirier B; Garin D; Tissier MH; Fuchs F; Crance JM J Clin Virol; 2005 Jan; 32(1):47-52. PubMed ID: 15572006 [TBL] [Abstract][Full Text] [Related]
19. [Method of titration of vaccinia and smallpox viruses and of neutralizing antibodies]. SOLOV'EV VD; MASTIUKOVA IuN Vopr Virusol; 1958; 3(6):342-6. PubMed ID: 13636150 [No Abstract] [Full Text] [Related]
20. Vaccinia virus H3L envelope protein is a major target of neutralizing antibodies in humans and elicits protection against lethal challenge in mice. Davies DH; McCausland MM; Valdez C; Huynh D; Hernandez JE; Mu Y; Hirst S; Villarreal L; Felgner PL; Crotty S J Virol; 2005 Sep; 79(18):11724-33. PubMed ID: 16140750 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]